# Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia

> **NCT01861535** · PHASE3 · COMPLETED · sponsor: **Medical University of Graz** · enrollment: 110 (actual)

## Conditions studied

- Vulvar Intraepithelial Neoplasia

## Interventions

- **DRUG:** Imiquimod
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT01861535
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2021-02
- **Final completion:** 2021-02
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2021-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01861535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01861535, "Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01861535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*